Verilumia 
Novartis, BMS Pause Autoimmune CAR-T Trials After Deaths
Novartis has paused eight clinical trials of an experimental cell therapy for autoimmune and neurological diseases after three patients died from a severe immune reaction, a setback for a promising approach to treating c...
